1.Protective effects of vitamin B12, ginseng saponin, and folic acid against murine fetal deformities caused by hyperthermia.
Helian LI ; Bowei WANG ; Dan ZHAO ; Liying HAN
Chinese Medical Journal 2003;116(11):1776-1778
OBJECTIVETo investigate the protective effects of vitamin B(12), ginseng saponin, and folic acid on mouse embryos subjected to high heat.
METHODSMice were used for the experiment.
RESULTSAfter exposure of pregnant mice to high heat, the rates of teratism, stillbirth, and fetal absorption were markedly lower in mice treated with ginseng saponin and folic acid following heat exposure than in untreated mice. There were no significant differences in these rates when comparing mice treated with vitamin B(12) with the untreated mice.
CONCLUSIONSGinseng saponin and folic acid can lessen injuries to murine embryos caused by high heat, while vitamin B(12) has little protective effect against high temperature except for promoting overall embryonic growth.
Animals ; Congenital Abnormalities ; prevention & control ; Fetal Diseases ; Fever ; complications ; Folic Acid ; therapeutic use ; Ginsenosides ; therapeutic use ; Mice ; Panax ; Saponins ; therapeutic use ; Vitamin B 12 ; therapeutic use
2.Review of study on the mechanism of active ingredients of single Chinese drug in treating intracerebral hemorrhage.
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(4):376-380
Domestic and overseas literature of clinical and experimental study in recent years concerning treatment of intracerebral hemorrhage (ICH) by active ingredients of single Chinese drug was reviewed, and the therapeutic mechanism, acting pathways and clinical effect of these ingredients were also explored in this paper.
Animals
;
Cerebral Hemorrhage
;
drug therapy
;
Drugs, Chinese Herbal
;
chemistry
;
therapeutic use
;
Humans
;
Panax notoginseng
;
chemistry
;
Phytotherapy
;
Saponins
;
therapeutic use
3.Therapeutic effects of saponins from Achyranthes bidentata in SHRsp.
Lijun WANG ; Yan ZHU ; Maochuan LIAO
China Journal of Chinese Materia Medica 2011;36(9):1239-1241
OBJECTIVETo study the therapeutic effects of saponins from Achyranthes bidentata (SAB) in stroke-prone sponyaneously hypertension rats (SHRsp).
METHODSixty SHRsp were randomly divided into five groups: SAB 0.10, 0.20, 0.40 g x kg(-1), Huatuo Zaizao pill group (positive control group) 2.5 g x kg(-1) and pathologic group (n=10). SAB and Huatuo Zaizao pill were used through filing stomach everyday for 20 days, pathologic group was given distilled water. The effects of SAB on blood pressure, changes of nerve state, death rate, brain index and the pathologic changes of hippocampal neuron of SHRsp were observed.
RESULTSAB could markedly decrease brain index, death rate of SHRsp after stroke. SAB could improve nerve state of SHRsp after stroke. Also SAB could prolong survival time and prevent pathologic change of hippocampal neuron of SHRsp after stroke.
CONCLUSIONSAB is advantageous of therapying the stroke in SHRsp.
Achyranthes ; chemistry ; Animals ; Antihypertensive Agents ; therapeutic use ; Hypertension ; drug therapy ; Male ; Random Allocation ; Rats ; Rats, Inbred SHR ; Saponins ; therapeutic use
5.Therapeutic effects of Trigonella foenum-greacum saponin on rats with alcoholic fatty livers.
Yan-zhi ZHANG ; Yu ZHANG ; Lin-lin LI ; Wei-xing YANG ; Xin-jian RAN ; Yong-xin YANG ; Xin-min MAO
Chinese Journal of Hepatology 2006;14(11):854-856
Animals
;
Fatty Liver, Alcoholic
;
drug therapy
;
Female
;
Male
;
Phytotherapy
;
Rats
;
Rats, Wistar
;
Saponins
;
therapeutic use
;
Trigonella
6.Treatment of Chronic Aplastic Anemia with Chinese Patent Medicine Pai-Neng-Da Capsule () for Replacing Androgen Partially: A Clinical Multi-Center Study.
Zhi-Yong JIANG ; Fang-Quan YU ; Rui-Lan GAO ; Yue-Min KUANG ; Yan ZHU ; Yue-Hua CHEN ; Lin-Jie LI ; Gui-Fang OUYANG ; Jing HU ; Xiao-Long WU
Chinese journal of integrative medicine 2022;28(1):20-27
OBJECTIVE:
To evaluate the efficacy and safety of Pai-Neng-Da Capsule (, panaxadiol saponins component, PNDC) in combination with the cyclosporine and androgen for patients with chronic aplastic anemia (CAA).
METHODS:
A total of 79 CAA patients was randomly divided into 2 groups by a random number table, including PCA group [43 cases, orally PNDC 320 mg/d plus cyclosporine 5 mg/(kg·d) plus andriol 80 mg/d] and CA group [36 cases, orally cyclosporine 5 mg/(kg·d) plus andriol 160 mg/d]. All patients were treated and followed-up for 6 treatment courses over 24 weeks. The complete blood counts, score of Chinese medical (CM) symptoms were assessed and urine routine, electrocardiogram, hepatic and renal function were observed for safety evaluation. Female masculinization rating scale was established according to the actual clinical manifestations to evaluate the accurate degree of masculinization in female CAA patients treated by andriol.
RESULTS:
The effective rates were 88.1% (37/42) in the PCA group and 77.8% (28/36) in the CA group based on the standard for the therapeutic efficacy evaluation of hematopathy. There was no significant difference in the white blood cell (WBC) counts, platelet counts and hemoglobin concentration of peripheral blood between two groups after 6 months treatment. The masculinization score of female patient in the PCA group was significantly lower than the CA group (P<0.05). The mild abdominal distention was observed in 1 cases in the PCA group. In CA group, the abnormalities in the hepatic function developed in 2 cases and the renal disfunction was found in 1 case.
CONCLUSION
The PNDC possesses certain curative effects in the treatment of CAA without obvious side-effects and can partially replace andriol thereby to reduce the degree of masculinization [Registried at Chinese Clinical Trial Registry (ChicTR1900028153)].
Androgens
;
Anemia, Aplastic/drug therapy*
;
China
;
Female
;
Humans
;
Nonprescription Drugs
;
Saponins/therapeutic use*
7.Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients.
Chun-Mei WANG ; Xiang-Feng GUO ; Li-Min LIU ; Ying HUANG ; Liang MENG ; Li-Po SONG ; Ying-Feng WU ; Ya-Chan NING ; Kathleen H REILLY ; Hai-Bo WANG
Chinese journal of integrative medicine 2022;28(9):771-778
OBJECTIVE:
To evaluate the efficacy of deep vein thrombosis (DVT) prevention among real-world surgical inpatients who received panax notoginseng saponins (PNS) combined with low-molecular-weight heparin (LMWH).
METHODS:
A prospective cohort study was conducted among surgical patients between January 2016 and November 2018 in Xuanwu Hospital, Capital Medical University, Beijing, China. Participants received LMWH alone or PNS combined with LMWH for preventing DVT. The primary outcome was incidence of lower extremity DVT, which was screened once a week. Participants in the LMWH group were given LMWH (enoxaparin) via hypodermic injection, 4000-8000 AxalU once daily. Participants in the exposure group received PNS (Xuesaitong oral tablets, 100 mg, 3 times daily) combined with LMWH given the same as LMWH group.
RESULTS:
Of the 325 patients screened for the study, 281 participants were included in the final analysis. The cohort was divided into PNS + LMWH group and LMWH group with 134 and 147 participants, respectively. There was a significant difference of DVT incidence between two groups (P=0.01), with 21 (15.7%) incident DVT in the PNS + LMWH group, and 41 (27.9%) incident DVT in the LMWH group. Compared with participants without DVT, the participants diagnosed with DVT were older and had higher D-dimer level. The multivariate logistic regression model showed a significant lower risk of incident DVT among participants in the PNS + LMWH group compared with the LMWH group (odds ratio 0.46, 95% confidence interval, 0.25-0.86). There were no significant differences in thromboelaslography values (including R, K, Angle, and MA) and differences in severe bleeding between two groups. No symptomatic pulmonary embolism occurred during the study.
CONCLUSION
Combined application of PNS and LMWH can effectively reduce the incidence of DVT among surgical inpatients compared with LMWH monotherapy, without increased risk of bleeding.
Anticoagulants/therapeutic use*
;
Hemorrhage
;
Heparin, Low-Molecular-Weight/therapeutic use*
;
Humans
;
Panax notoginseng
;
Prospective Studies
;
Saponins/therapeutic use*
;
Venous Thrombosis/prevention & control*
8.Mining chemodiversity from biodiversity: pharmacophylogeny of medicinal plants of Ranunculaceae.
Da-Cheng HAO ; Pei-Gen XIAO ; Hong-Ying MA ; Yong PENG ; Chun-Nian HE
Chinese Journal of Natural Medicines (English Ed.) 2015;13(7):507-520
This paper reports a pharmacophylogenetic study of a medicinal plant family, Ranunculaceae, investigating the correlations between their phylogeny, chemical constituents, and pharmaceutical properties. Phytochemical, ethnopharmacological, and pharmacological data were integrated in the context of the systematics and molecular phylogeny of the Ranunculaceae. The chemical components of this family included several representative metabolic groups: benzylisoquinoline alkaloids, ranunculin, triterpenoid saponin, and diterpene alkaloids, among others. Ranunculin and magnoflorine were found to coexist in some genera. The pharmacophylogenetic analysis, integrated with therapeutic information, agreed with the taxonomy proposed previously, in which the family Ranunculaceae was divided into five sub-families: Ranunculoideae, Thalictroideae, Coptidoideae, Hydrastidoideae, and Glaucidioideae. It was plausible to organize the sub-family Ranunculoideae into ten tribes. The chemical constituents and therapeutic efficacy of each taxonomic group were reviewed, revealing the underlying connections between phylogeny, chemical diversity, and clinical use, which should facilitate the conservation and sustainable utilization of the pharmaceutical resources derived from the Ranunculaceae.
Alkaloids
;
analysis
;
therapeutic use
;
Aporphines
;
analysis
;
therapeutic use
;
Biodiversity
;
Furans
;
analysis
;
Humans
;
Methylglycosides
;
analysis
;
Phylogeny
;
Phytotherapy
;
Plant Extracts
;
chemistry
;
therapeutic use
;
Plants, Medicinal
;
chemistry
;
Ranunculaceae
;
chemistry
;
Saponins
;
analysis
;
therapeutic use
;
Terpenes
;
analysis
;
therapeutic use
9.Advances in research on pharmacological and neuroprotective effects of traditional Chinese medicine after cerebral ischemia.
Min WANG ; Jian-Xun LIU ; Ming-Jiang YAO ; Jun-Guo REN
China Journal of Chinese Materia Medica 2020;45(3):513-517
Cerebral ischemia is also known as ischemic stroke. In recent years, research on neuroprotection after ischemia has became a hot spot as stroke can result in symptoms of nerve damages such as hemiplegia, learning and memory disorders. The key factors that cause the death of cells include excitotoxicity, oxidative damage, nitrosative stress and inflammation. However, there is no effective preparation for the treatment of post-ischemic nerve defects at present, so it is urgent to find and develop effective drugs for the treatment of nerve damages after ischemia. Traditional Chinese medicine has advantages and potentials in the treatment of neurological diseases. Many scholars have carried out related researches on the active ingredients of traditional Chinese medicine and achieved some good results. In this context, the researches on the neuroprotective effects of traditional Chinese medicines such as tetramethylpyrazine, butylphthalide and total saponins of Panax notoginseng were reviewed. The author found that the neuroprotective researches of traditional Chinese medicine mostly focused on anti-apoptosis, anti-inflammatory and anti-oxidative stress, but those effects were not sounique to the nervous system. Furthermore, most ingredients of traditional Chinese medicine showed a poor water-soluble property. In view of the research status and existing problems of traditional Chinese medicine in nerve injury, the suggestions for the research and development of the potent neuroprotective agents were proposed in this study from the perspective of pharmacological mechanism research and preparation theory.
Benzofurans/therapeutic use*
;
Brain Ischemia/drug therapy*
;
Cerebral Infarction/drug therapy*
;
Drugs, Chinese Herbal/therapeutic use*
;
Humans
;
Medicine, Chinese Traditional
;
Neuroprotective Agents/therapeutic use*
;
Panax notoginseng
;
Pyrazines/therapeutic use*
;
Saponins/therapeutic use*
10.Aike mixture has good anti-inflammatory and analgesic effects on mice.
Min-jian ZHANG ; Ke-dan CHU ; Xin-ling CHENG ; Xu-dong PAN ; Wan-jun CHENG ; Kai-yuan YU ; Yu-hong TAN ; Jin-zhi LIU ; Ya-lei SHI ; Sheng ZHENG ; Qiao-bin LIU
National Journal of Andrology 2007;13(5):471-473
OBJECTIVETo study the anti-inflammatory and analgesic actions of Aike Mixture (AKM).
METHODSA total of 100 male mice were randomly assigned into 5 groups: a normal control group, a drug control group (a hydrocortisone subgroup and an atropine subgroup), a high-dose AKM group, a mid-dose AKM group and a low-dose AKM group. Xylene was spread on the left ear of the experimental mice to induce inflammation, and 1% acetic acid solution injected into the abdominal cavity to produce pain so as to cause the body bend. Different doses of AKM were given and their actions observed.
RESULTSAKM had obvious anti-inflammatory effect on the xylene-induced ear tumefaction and inhibited the pain-caused body bend in the AKM groups, with significant difference from the normal control (P < 0.01).
CONCLUSIONAKM has good anti-inflammatory and analgesic effects, which is of clinical significance in the treatment of chronic prostatitis.
Animals ; Chronic Disease ; Disease Models, Animal ; Drug Combinations ; Male ; Mice ; Mice, Inbred ICR ; Oleanolic Acid ; analogs & derivatives ; pharmacology ; therapeutic use ; Phytotherapy ; Prostatitis ; drug therapy ; Saponins ; pharmacology ; therapeutic use